Advancements in Targeted Therapies for Vitiligo: Prioritizing Equity in Drug Development.

Delva, Camile; Pearson, Todd F; Harris, John E

Delva, Camile; Pearson, Todd F; Harris, John E.

Afiliación

Delva C; Camile Delva is from the CUNY School of Medicine, New York, New York. Drs. Pearson and Harris are from the Department of Dermatology, UMass Chan Medical School, Worcester.
Pearson TF; Camile Delva is from the CUNY School of Medicine, New York, New York. Drs. Pearson and Harris are from the Department of Dermatology, UMass Chan Medical School, Worcester.
Harris JE; Camile Delva is from the CUNY School of Medicine, New York, New York. Drs. Pearson and Harris are from the Department of Dermatology, UMass Chan Medical School, Worcester.

Cutis ; 113(4): 156-158, 2024 Apr.

Article en En | MEDLINE | ID: mdl-38820107

Asunto(s)

Desarrollo de Medicamentos; Vitíligo; Humanos; Vitíligo/tratamiento farmacológico; Fármacos Dermatológicos/uso terapéutico; Terapia Molecular Dirigida

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Desarrollo de Medicamentos Límite: Humans Idioma: En Revista: Cutis Año: 2024 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google